DR. SCOTT MICHAEL WASSERMAN, MD
Osteopathic Medicine at Via Pisa, Thousand Oaks, CA

License number
California AA66175
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California AA66175
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
5238 Via Pisa, Thousand Oaks, CA 91320
Phone
(805) 375-8293

Professional information

Scott Wasserman Photo 1

Executive Director At Amgen

Position:
Executive Medical Director at Amgen
Location:
Greater Los Angeles Area
Industry:
Biotechnology
Work:
Amgen - Thousand Oaks, CA since Jun 2005 - Executive Medical Director Millennium 2002 - 2003 - Post-doc
Education:
Harvard Medical School 1992 - 1997


Scott Wasserman Photo 2

Methods Of Treating Or Preventing Cholesterol Related Disorders

US Patent:
2013006, Mar 14, 2013
Filed:
May 10, 2012
Appl. No.:
13/469032
Inventors:
Joyce Chi Yee Chan - San Francisco CA, US
John P. Gibbs - Mercer Island WA, US
Clapton S. Dias - Newbury Park CA, US
Scott Wasserman - Newbury Park CA, US
Robert Andrew Donald Scott - Thousand Oaks CA, US
Christi L. Clogston - Camarillo CA, US
Timothy David Osslund - Camarillo CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 39/395, A61P 3/06
US Classification:
4241391, 4241411, 4241581
Abstract:
The present invention relates to methods of treating or preventing cholesterol related disorders, such as hypercholesterolemia, hyperlipidemia or dyslipidemia, using antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9). Formulations and methods of producing said formulations are also described.


Scott Wasserman Photo 3

Methods For Treating Or Preventing Cholesterol Related Disorders

US Patent:
2014000, Jan 2, 2014
Filed:
Jun 28, 2013
Appl. No.:
13/931716
Inventors:
John P. GIBBS - Mercer Island WA, US
Clapton S. DIAS - Newbury Park CA, US
Robert Andrew Donald SCOTT - Thousand Oaks CA, US
Evan A. STEIN - Chicago IL, US
Scott WASSERMAN - Newbury Park CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
C07K 16/40, A61K 39/395, A61K 31/40, A61K 31/366, A61K 31/505
US Classification:
4241391
Abstract:
The present invention relates to methods of treating or preventing cholesterol related disorders, such as hypercholesterolemia, hyperlipidemia or dyslipidemia, using antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9). Formulations and methods of producing said formulations are also described.